End-of-day quote
Other stock markets
|
||
- USD | - |
04-25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M 1.93B |
---|---|---|---|---|---|
Net income 2022 | -9M -709M | Net income 2023 | -5M -394M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M 3.31B | Net cash position 2023 | 37.15M 2.93B | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 30/09/06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 09/05/21 |
Sharon Perry
LAW | General Counsel | - | 31/12/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 15/02/17 |
Robert Conway
CHM | Chairman | 70 | 02/09/13 |
Linda Grais
BRD | Director/Board Member | 68 | 30/04/07 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |